$100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
$100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
Biomarin Pharmaceutical (NASDAQ:BMRN) has outperformed the market over the past 20 years by 6.44% on an annualized basis producing an average annual return of 14.87%. Currently, Biomarin Pharmaceutical has a market capitalization of $16.09 billion.
在過去的20年中，Biomarin Pharmaceutical（納斯達克股票代碼：BMRN）的年化表現比市場高6.44％，平均年回報率爲14.87％。目前，Biomarin Pharmaceutical的市值爲160.9億美元。
Buying $100 In BMRN: If an investor had bought $100 of BMRN stock 20 years ago, it would be worth $1,718.66 today based on a price of $84.73 for BMRN at the time of writing.
購買100美元的BMRN股票：如果投資者在20年前購買了100美元的BMRN股票，那麼按撰寫本文時BMRN的84.73美元的價格計算，今天的價值將爲1718.66美元。
Biomarin Pharmaceutical's Performance Over Last 20 Years
Biomarin Pharmaceutical在過去 20 年的表現
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
最後，這一切的意義何在？從本文中得出的關鍵見解是，在一段時間內，複合回報可以對您的現金增長產生多大的影響。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
